РОЛЬ ДЕЗИНТОКСИКАЦИОННОЙ И АНТИОКСИДАНТНОЙ ТЕРАПИИ В ЛЕЧЕНИИ COVID-19: ТЕОРИЯ И ПРАКТИКА

ПРЕПРИНТ

Эта статья является препринтом и не была отрецензирована.
О результатах, изложенных в препринтах, не следует сообщать в СМИ как о проверенной информации.

Хавкина Д. А.,

Руженцова Т. А.,

Чухляев П. В.,

Гарбузов А. А.,

Шушакова Е. К.

2020-07-20

https://doi.org/10.21055/preprints-3111722

Проанализировано более 30 литературных источников, содержащих данные о течении, диагностике и терапии Covid-19. Ни в одном источнике не упоминается о дезинтоксикационной и/или антиоксидантной терапии. Проанализированы три клинических случая COVID-19. На основе собственной клинической практики сформирована модель патогенеза COVID-19, которая обосновывает необходимость применения препаратов – дезинтоксикантов, сорбентов и антиоксидантов, как улучшающих течение, прогноз и исход заболевания. Клинические примеры, указанные в статье демонстрируют эффективность предложенной терапии. Сформированная модель патогенеза COVID-19 обоснована клинически и патофизиологически.

Ссылка для цитирования:

Хавкина Д. А., Руженцова Т. А., Чухляев П. В., Гарбузов А. А., Шушакова Е. К. 2020. РОЛЬ ДЕЗИНТОКСИКАЦИОННОЙ И АНТИОКСИДАНТНОЙ ТЕРАПИИ В ЛЕЧЕНИИ COVID-19: ТЕОРИЯ И ПРАКТИКА. COVID19-PREPRINTS.MICROBE.RU. https://doi.org/10.21055/preprints-3111722

Список литературы

1. World Health Organization. Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (Accessed on February 12, 2020).

2. Tang X, Wu C, Li X, et al. On the origin and continuing evolution of SARS-CoV-2. National Science Review 2020.

3. Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for Healthcare Professionals. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html (Accessed on February 14, 2020).

4. World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance (Accessed on February 14, 2020).

5. World Health Organization Director-General's opening remarks at the media briefing on COVID-19 - 24 February 2020 https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---24-february-2020 (Accessed on February 26, 2020).

6. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395:473.

7. European Centre for Disease Prevention and Control. Novel coronavirus in China. https://www.ecdc.europa.eu/en/novel-coronavirus-china (Accessed on January 23, 2020).

8. World Health Organization. WHO Disease outbreak news: Novel Coronavirus - Republic of Korea (ex-China). January 21, 2020. https://www.who.int/csr/don/21-january-2020-novel-coronavirus-republic-of-korea-ex-china/en/ (Accessed on January 21, 2020).

9. Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States, January 21, 2020. https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html (Accessed on January 21, 2020).

10. Centers for Disease Control and Prevention. Second travel-related case of 2019 novel coronavirus detected in United States, January 24, 2020. https://www.cdc.gov/media/releases/2020/p0124-second-travel-coronavirus.html (Accessed on January 24, 2020).

11. Day M. COVID-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020; 368:m1086.

12. Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020.

13. European Centre for Disease Prevention and Control. Geographical distribution of 2019-nCov cases. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases (Accessed on January 26, 2020).

14. Centers for Disease Control and Prevention. 2019 Novel Coronavirus (2019-nCoV) in the US. https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html (Accessed on February 10, 2020).

15. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020; 14:72.

16. Colson P, Rolain JM, Lagier JC, et al. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 2020; :105932.

17. Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID?19: results of an open?label non?randomized clinical trial. International Journal of Antimicrobial Agents - In Press 17 March 2020 DOI:10.1016/j.ijantimicag.2020.105949.

18. Groneberg DA, Poutanen SM, Low DE, et al. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005; 5:147.

19. Chan JF, Yao Y, Yeung ML, et al. Treatment With Lopinavir/Ritonavir or Interferon-?1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis 2015; 212:1904.

20. World Health Organization. Novel coronavirus situation report -2. January 22, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov.pdf (Accessed on January 23, 2020).

21. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19. N Engl J Med 2020.

22. Wang Y, Liu Y, Liu L, et al. Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China. J Infect Dis 2020.

23. Pan F, Ye T, Sun P, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology 2020; :200370.

24. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020.

25. Chang, Lin M, Wei L, et al. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA 2020.

26. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368:m606.

27. Wu J, Liu J, Zhao X, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis 2020.

28. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020.

29. Zhao W, Zhong Z, Xie X, et al. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol 2020; :1.

30. Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020; :200642.

31. Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 2020; :200823.

32. Xie X, Zhong Z, Zhao W, et al. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology 2020; :200343.

33. Centers for Disease Control and Prevention. Updated Guidance on Evaluating and Testing Persons for COVID-19. HAN429. https://emergency.cdc.gov/han/2020/han00429.asp?deliveryName=USCDC_511-DM22015 (Accessed on March 09, 2020).

34. Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19). February 14, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html (Accessed on March 15, 2020).

35. Patel A, Jernigan DB, 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:140.

36. World Health Organization. Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/surveillance-and-case-definitions (Accessed on February 28, 2020).

37. World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance: Patient management. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management (Accessed on February 02, 2020).

38. World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. Updated February 4, 2020. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts (Accessed on February 14, 2020).

39. Камкин Е.Г. и соавт. Профилактика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации Минздравсоцразвития РФ. Версия 6: https://static1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_МR_COVID-19_v6.pdf.

40. Электронный Российский справочник лекарственных средств: https://www.rlsnet.ru.

ПРЕПРИНТ

ИНФОРМАЦИЯ О ПРЕПРИНТЕ